...
首页> 外文期刊>Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research >Bioassay-guided isolation of cytotoxic compounds from Chrysophthalmum montanum (DC.) Boiss
【24h】

Bioassay-guided isolation of cytotoxic compounds from Chrysophthalmum montanum (DC.) Boiss

机译:来自甲肾上腺素(DC.)博物馆(DC.)博物馆(DC.)的细胞毒性化合物的生物测定和分离

获取原文
获取原文并翻译 | 示例

摘要

Bioassay-guided isolation of the 80% methanol extract of the aerial parts of Chrysophthalmum montanum (DC.) Boiss. (Asteraceae) led to the isolation of four known guaianolide-type sesquiterpene lactones, 6 alpha-acetoxy-4 alpha-hydroxy-113H-guaia-9.11(13)-dien-12.8a-olide (1), 6 alpha-acetoxy-4 alpha-hydroxy-9 beta.10 beta-epoxy-1 beta H-guaia-11(13)-en12.8 alpha-olide (2), 4 alpha,6 alpha-dihydroxy-1 beta H,5 alpha,7 alpha H-guaia-9(10),11(13)-dien-12,8 alpha-olide (3), and (4 alpha,5 alpha,8 beta,10 beta)-4,10-dihydroxy-1,11(13)-guaidien-12,8-olide (4), along a steroidal glycoside mixture (5a and 5b). The structures of the compounds were identified on the basis of spectroscopic data. Among them, 2, 4 and a steroidal glycoside mixture were obtained from C. montanum for the first time. All isolates were also first time assayed for in vitro cytotoxicities against four human cancer cell lines, i.e. breast (MCF-7, MDA-MB 231), colon (FIT-29), and lung (PC3). Among the isolates, 1-3 showed significant inhibitory effect on the proliferation of cancer cells with viability ranging from 6.86 to 26.51%, while steroidal glycoside mixture showed no cytotoxicity, except against HT-29 (viability 61.99%). Compound 4 exhibited strong and selective cell growth inhibition against HT-29 with viability 20.99% and was identified as a promising compound with high selectivity between cancer cells and normal human lung cells (SEAS-2B), especially against HT-29 (IC50 = 12.2 pg/mL) compared to that of cisplatin. These results suggested that 4 is worthy of further study to determine its cytotoxicity mechanisms.
机译:生物测定引导的乳糜胺(DC)乳头氏菌(DC。)的80%甲醇提取物的分离。 (Asteraceae)导致了四种已知的胍型酪蛋白萜烯内酯萜烯乳蛋白蛋白质乳蛋白,6α-乙酰氧基-4α-羟基-113H-GUAIA-9.11(13)-dien-12.8a-olide(1),6α-乙酰氧基 - 4α-羟基-9β.10β-环氧-1βH-GUAIA-11(13)-en12.8α-奥莱德(2),4α,6α-二羟基-1βH,5α,7 αH-Guaia-9(10),11(13) - 浓度-12,8α-olide(3),以及(4α,5α,8β,10β)-4,10-二羟基-1, 11(13)-Guaidien -12,8-烯胺(4),沿甾体糖苷混合物(5a和5b)。基于光谱数据鉴定化合物的结构。其中,第一次从C. montanum获得2,4和甾体糖苷混合物。所有分离物也首次测定用于对四种人癌细胞系的体外细胞毒性,即乳腺(MCF-7,MDA-MB 231),结肠(FIT-29)和肺(PC3)。在分离物中,1-3显示出对癌细胞增殖的显着抑制作用,其活力范围为6.86至26.51%,而甾体糖苷混合物显示出没有细胞毒性,除了HT-29外,除了HT-29之外(活力61.99%)。化合物4对HT-29具有强大而选择性的细胞生长抑制,具有20.99%的活力,并被鉴定为具有癌细胞和正常人肺细胞(SEA-2B)之间的具有高选择性的有希望的化合物,特别是对HT-29(IC50 = 12.2与顺铂相比,pg / ml。这些结果表明,4值得进一步研究以确定其细胞毒性机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号